Related references
Note: Only part of the references are listed.Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951
Mathilde C. M. Kouwenhoven et al.
NEURO-ONCOLOGY (2009)
Anaplastic oligodendroglial tumors: Refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402
Caterina Giannini et al.
BRAIN PATHOLOGY (2008)
BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas
Stefan Pfister et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Gene amplification is a poor prognostic factor in anaplastic oligodendrogliomas
Ahmed Idbaih et al.
NEURO-ONCOLOGY (2008)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas
Ahmed Idbaih et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
1p36 is a preferential target of chromosome 1 deletions in astrocytic tumours and homozygously deleted in a subset of glioblastomas
K. Ichimura et al.
ONCOGENE (2008)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Panel review of anaplastic oligodendroglioma from European Organization for Research and Treatment of Cancer Trial 26951: Assessment of consensus in diagnosis, influence of 1p/19q loss, and correlations with outcome
Johan M. Kros et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2007)
Identification of genomic aberrations associated with shorter overall survival in patients with oligodendroglial tumors
Detlef Trost et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Significance of necrosis in grading of oligodendroglial neoplasms: A clinicopathologic and genetic study of newly diagnosed high-grade gliomas
C. Ryan Miller et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities
Elizabeth A. Maher et al.
CANCER RESEARCH (2006)
A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma
Robert B. Jenkins et al.
CANCER RESEARCH (2006)
High-resolution global genomic survey of 178 gliomas reveals novel regions of copy number alteration and allelic imbalances
Yuri Kotliarov et al.
CANCER RESEARCH (2006)
1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment
Mathilde C. M. Kouwenhoven et al.
EUROPEAN JOURNAL OF CANCER (2006)
Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss
Constance A. Griffin et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Application of array CGH on archival formalin-fixed paraffin-embedded tissues including small numbers of microdissected cells
Nicola A. Johnson et al.
LABORATORY INVESTIGATION (2006)
Multiplex ligation-dependent probe amplification - A diagnostic tool for simultaneous identification of different genetic markers in glial tumors
Judith Jeuken et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2006)
CAPweb:: a bioinformatics CGH array Analysis Platform
Stephane Liva et al.
NUCLEIC ACIDS RESEARCH (2006)
Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial
Martin J. van den Bent et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402
Gregory Cairncross et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Glioma test array for use with formalin-fixed, paraffin-embedded tissue - Array comparative genomic hybridization correlates with loss of heterozygosity and fluorescence in situ hybridization
Gayatry Mohapatra et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2006)
Molecular classification of human gliomas using matrix-based comparative genomic hybridization
P Roerig et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Two types of chromosome 1p losses with opposite significance in gliomas
A Idbaih et al.
ANNALS OF NEUROLOGY (2005)
High-resolution genome-wide mapping of genetic alterations in human glial brain tumors
M Bredel et al.
CANCER RESEARCH (2005)
Array comparative genomic hybridization identifies genetic subgroups in grade 4 human astrocytoma
A Misra et al.
CLINICAL CANCER RESEARCH (2005)
Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma
JM Nigro et al.
CANCER RESEARCH (2005)
Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas
G Kitange et al.
GENES CHROMOSOMES & CANCER (2005)
Identification of consistent novel submegabase deletions in low-grade oligodendrogliomas using array-based comparative genomic hybridization
MR Rossi et al.
GENES CHROMOSOMES & CANCER (2005)
The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas
KL Ligon et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas
KB Fallon et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
Characterization of the 1p/19q chromosomal loss in oligodendrogliomas using comparative genomic hybridization arrays (CGHa)
JK Cowell et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
Small cell astrocytoma: An aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma
A Perry et al.
CANCER (2004)
Genetic pathways to glioblastoma:: A population-based study
H Ohgaki et al.
CANCER RESEARCH (2004)
Detrended fluctuation analysis of genome-wide copy number profiles of glioblastomas using array-based comparative genomic hybridization
Y Nakahara et al.
NEURO-ONCOLOGY (2004)
Clinical utility of fluorescence in situ hybridization (FISH) in morphologically ambiguous gliomas with hybrid oligodendroglial/astrocytic features
CE Fuller et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
The WHO classification of tumors of the nervous system
P Kleihues et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
Glioma classification - A molecular reappraisal
DN Louis et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
OLIG2 as a specific marker of oligodendroglial tumour cells
Y Marie et al.
LANCET (2001)
Detection of multiple gene amplifications in glioblastoma multiforme using array-based comparative genomic hybridization
ABY Hui et al.
LABORATORY INVESTIGATION (2001)
Oligodendrogliomas: Reproducibility and prognostic value of histologic diagnosis and grading
C Giannini et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)
Share Paper
